Skip to main content
Wacker Chemie AG logo

Wacker Chemie AG — Investor Relations & Filings

Ticker · WCH ISIN · DE000WCH8881 LEI · 0NURKC5Q3CJYZPPK5046 F Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2017-12-07 Board/Management Inform…
Country DE Germany
Listing F WCH

About Wacker Chemie AG

https://www.wacker.com/cms/en-de/home/h…

Wacker Chemie AG is a technology-focused chemical and biotechnology company that develops and manufactures a wide range of specialty products for global markets. The company's core activities are centered on silicone and polymer chemistry, providing advanced solutions for various sectors, including construction additives. A significant part of its business is Wacker Biotech, which operates as a full-service contract development and manufacturing organization (CDMO). This division specializes in the microbial-based production of therapeutic proteins, plasmid DNA (pDNA), messenger ribonucleic acid (mRNA), live microbial products (LMPs), and vaccines for the pharmaceutical and life sciences industries.

Recent filings

Filing Released Lang Actions
Wacker Chemie AG: Supervisory Board Extends the Contracts of CEO Rudolf Staudigl and Executive Board Member Christian Hartel
Board/Management Information Classification · 100% confidence The document is a news release dated December 7, 2017, announcing the extension of contracts for the CEO (Rudolf Staudigl) and an Executive Board Member (Christian Hartel) of Wacker Chemie AG. The key phrase is "Change of Personnel" and the content details appointments and contract extensions for senior management. This directly aligns with the definition for Board/Management Information (MANG). It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2017-12-07 English
Wacker Chemie AG: AFTER A STRONG Q3 WACKER EXPECTS TO POST FULL-YEAR EBITDA OF EUR1 BILLION
Earnings Release Classification · 100% confidence The document text explicitly discusses 'Quarter Results' for Q3 2017, providing detailed financial metrics (Sales, EBITDA, Net Income, Cash Flow) for the quarter and nine months, and includes an updated full-year earnings forecast. The header mentions 'Wacker Chemie AG: AFTER A STRONG Q3 WACKER EXPECTS TO POST FULL-YEAR EBITDA OF EUR1 BILLION' and the DGAP tag indicates 'Quarter Results'. This content structure—detailed quarterly performance figures and forward-looking guidance based on the quarter—is characteristic of an Earnings Release (ER) or an Interim Report (IR). Since the document provides comprehensive segment breakdowns and detailed financial tables, it goes beyond a simple 'Earnings Release' (ER) which usually contains only key highlights. It aligns best with the definition of a comprehensive financial report for a period shorter than a year, which is the 'Interim / Quarterly Report' (IR). The text also mentions 'Interim Report for Q3 2017' near the end, confirming this classification. Q3 2017
2017-10-26 English
Q3 statement / Q3 financial report 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' for the period 'January through September 2017'. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed segment performance analysis (Sales, EBITDA, EBIT). It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-10-26 English
Wacker Chemie AG: WACKER to Build new Production Facilities for Dispersions and Polymer Powders in South Korea
Regulatory Filings Classification · 100% confidence The document is a news release dated September 28, 2017, announcing Wacker Chemie AG's plan to build new production facilities in South Korea. It details capital expenditures (EUR60 million), capacity expansion (80,000 metric tons/year), and project timelines (completion by Q1 2019). This announcement concerns a significant investment and expansion of production capacity, which falls under corporate financing or capital structure changes, although it is primarily an operational expansion announcement. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it involves a major capital expenditure (EUR60 million) for expansion. It is not a standard regulatory filing like 10-K or ER, nor is it a management change or dividend notice. Since it is a specific announcement about a major investment, CAP is preferred over the general fallback RNS.
2017-09-28 English
Datum:04.08.2017
Environmental & Social Information Classification · 100% confidence The document is a 'Zahlungsbericht' (Payment Report) for Wacker Chemie AG for the fiscal year 2016, prepared in accordance with German commercial law (HGB) regarding payments to government entities in the extractive industry. It is a standalone regulatory disclosure report detailing specific financial payments (taxes, royalties, fees) rather than a general annual report, earnings release, or announcement. Since it is a specific regulatory disclosure report required by law (HGB sections 341q-341w) and does not fit into the other specific categories like 10-K or IR, it is best classified as a Regulatory Filing.
2017-08-04 German
Wacker Chemie AG: AFTER A SOLID SECOND QUARTER, WACKER RAISES ITS FORECAST FOR FULL-YEAR 2017
Earnings Release Classification · 100% confidence The document is a press release dated July 28, 2017, detailing the financial results for the Second Quarter (Q2 2017) and the first half of 2017 for Wacker Chemie AG. It includes key performance indicators (Sales, EBITDA, Net Income), management commentary, divisional breakdowns, and an updated full-year forecast. The content is characteristic of an initial announcement of periodic financial results, focusing on key highlights and the revised outlook, rather than the comprehensive, audited report (10-K) or a detailed management discussion (MDA). The presence of 'Quarter Results/Half Year Results' in the keywords and the focus on Q2 performance strongly points towards an Earnings Release (ER). It is not a Call Transcript (CT) as it lacks Q&A structure, nor is it a full Interim Report (IR) which is typically more extensive and formally structured under regulatory filings, although it contains interim data. The document explicitly announces the results and the raised forecast. Q2 2017
2017-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.